Inaktiver Wert

Andere Sprachen Bausch Health Companies Inc Toronto S.E.

Aktien

CA91911K1021

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

Bausch + Lomb Reports "Statistically Significant" Results From Study of Nutritional Supplement for Dry Eyes	25.04.
Bausch + Lomb Brief: Announcing "Statistically Significant" Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes	25.04.
Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says	23.04.
RBC Previews Bausch Health's Q1, Trims Target to US$11	23.04.
RBC Cuts Bausch + Lomb Target to US$18, Reiterates Outperform, as Previews Q1	22.04.
Bausch Health's Issuer Credit Rating Upgraded by S&P	19.04.
Bausch Health Gets 'Positive' Court Ruling on Xifaxan With Market Odds of Bausch + Lomb Distribution at 32%, RBC Says	12.04.
RBC Notes "Positive" Appellate Court Ruling For Bausch Health, But Thinks Market Assigning ~32% BLCO Distribution Odds	12.04.
Bausch Health, Canada Inc. - Acne vulgaris treatment PrARAZLO now available to patients through British Columbia PharmaCare public drug plan	12.04.
Bausch Health Companies - Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029	12.04.
Bausch Health to Announce First-Quarter 2024 Results on May 2	12.04.
Bausch wins US appeal to block Alvogen generic of diarrhea drug	11.04.
Canadian Investment Regulatory Organization Trade Resumption - BHC	11.04.
Canadian Investment Regulatory Organization Trading Halt - BHC	11.04.
Bausch Health, Canada Inc. Announces Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan	11.04.
TSX ends flat as gold stocks drop, mood cautious ahead of rate decision	08.04.
Bausch Health Up Near 0.4% In US Premarket After Announcing Patent Lawsuit Against Amneal Pharmaceuticals	08.04.
North American Morning Briefing : Inflation Data, -2-	08.04.
Trump eyes $43 million haul from biggest fundraiser yet	06.04.
RBC Raises Bausch Health Target to US$12, Maintains Sector Perform, on Upcoming Xifaxan Litigation Ruling	05.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bausch Health Companies Inc Toronto S.E.

Aktien

CA91911K1021

Andere Sprachen

Filter